HW&C
HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
326
Vertex Pharmaceuticals
VRTX
$101B
|
AF
Andrew Fein
| $395.25 | $550 |
39%
upside
| Buy |
23 Jun ‘25
2 months ago |
|
327
Lineage Cell Therapeutics
LCTX
$283M
|
JP
Joseph Pantginis
| $1.24 | $9 |
626%
upside
| Buy |
23 Jun ‘25
2 months ago |
|
328
Cocrystal Pharma
COCP
$15.4M
|
RS
Raghuram Selvaraju
| $1.50 | $6 |
300%
upside
| Buy |
20 Jun ‘25
2 months ago |
|
329
Moleculin Biotech
MBRX
$11.8M
|
JP
Joseph Pantginis
| $0.3890 | $4 |
928%
upside
| Buy |
18 Jun ‘25
2 months ago |
|
330
Ardelyx
ARDX
$1.59B
|
MC
Matthew Caufield
| $6.59 | $10 |
52%
upside
| Buy |
18 Jun ‘25
2 months ago |
|
331
Roivant Sciences
ROIV
$8.82B
|
DT
Douglas Tsao
| $12.91 | $18 |
39%
upside
| Buy |
18 Jun ‘25
2 months ago |
|
|
WRN
332
Western Copper and Gold
WRN
$311M
|
HI
Heiko Ihle
| $1.54 | $4 |
160%
upside
| Buy |
18 Jun ‘25
2 months ago |
|
|
ELBM
333
Electra Battery Materials
ELBM
$15.4M
|
HI
Heiko Ihle
| $0.8583 | $2.20 |
156%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
334
Esperion Therapeutics
ESPR
$506M
|
JP
Joseph Pantginis
| $2.51 | $16 |
537%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
335
Galectin Therapeutics
GALT
$299M
|
JP
Joseph Pantginis
| $4.67 | $6 |
28%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
|
BLRX
336
BioLineRX
BLRX
$15.5M
|
JP
Joseph Pantginis
| $3.64 | $26 |
614%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
337
Solid Biosciences
SLDB
$399M
|
AH
Arthur He
| $5.13 | $20 |
290%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
338
Aquestive Therapeutics
AQST
$606M
|
RS
Raghuram Selvaraju
| $5.01 | $10 |
100%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
|
PPTA
339
Perpetua Resources
PPTA
$1.94B
|
HI
Heiko Ihle
| $18.06 | $27.50 |
52%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
340
Intellia Therapeutics
NTLA
$1.27B
|
MK
Mitchell Kapoor
| $11.84 | $30 |
153%
upside
| Buy |
16 Jun ‘25
2 months ago |
|
341
Arcellx
ACLX
$3.94B
|
EB
Emily Bodnar
| $71.11 | $115 |
62%
upside
| Buy |
16 Jun ‘25
2 months ago |
|
|
SLN
342
Silence Therapeutics
SLN
$254M
|
PT
Patrick Trucchio
| $5.38 | $75 |
1,294%
upside
| Buy |
13 Jun ‘25
2 months ago |
|
|
RZLV
343
Rezolve AI PLC Ordinary Shares
RZLV
$1.13B
|
SB
Scott Buck
| $4.62 | $4 |
13%
downside
| Buy |
13 Jun ‘25
2 months ago |
|
344
Gold Royalty Corp
GROY
$654M
|
HI
Heiko Ihle
| $3.83 | $5.75 |
50%
upside
| Buy |
13 Jun ‘25
2 months ago |
|
345
Westwater Resources
WWR
$61.8M
|
HI
Heiko Ihle
| $0.7171 | $2 |
179%
upside
| Buy |
12 Jun ‘25
2 months ago |
|
346
Cabaletta Bio
CABA
$154M
|
DT
Douglas Tsao
| $1.68 | $25 |
1,388%
upside
| Buy |
11 Jun ‘25
2 months ago |
|
347
Insmed
INSM
$31B
|
AF
Andrew Fein
| $146.68 | $120 |
18%
downside
| Buy |
11 Jun ‘25
2 months ago |
|
348
Travere Therapeutics
TVTX
$1.89B
|
EA
Ed Arce
| $21.20 | $30 |
42%
upside
| Buy |
11 Jun ‘25
2 months ago |
|
|
ARTV
349
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$75.5M
|
EB
Emily Bodnar
| $3.09 | $12 |
288%
upside
| Buy |
11 Jun ‘25
2 months ago |
|
350
GRI Bio
GRI
$3.92M
|
JP
Joseph Pantginis
| $1.56 | $10 |
541%
upside
| Buy |
11 Jun ‘25
2 months ago |
|